| Deem Therapeutic And Counseling Services Pllc | |
|
27841 Bowker Dr Le Claire IA 52753-9780 | |
| (281) 753-6681 | |
| Not Available |
| Full Name | Deem Therapeutic And Counseling Services Pllc |
|---|---|
| Speciality | Counselor |
| Location | 27841 Bowker Dr, Le Claire, Iowa |
| Authorized Official Name and Position | Emma Marie Deem (OWNER/THERAPIST) |
| Authorized Official Contact | 2817536681 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Deem Therapeutic And Counseling Services Pllc 27841 Bowker Dr Le Claire IA 52753-9780 Ph: (281) 753-6681 | Deem Therapeutic And Counseling Services Pllc 27841 Bowker Dr Le Claire IA 52753-9780 Ph: (281) 753-6681 |
| NPI Number | 1477230050 |
|---|---|
| Provider Enumeration Date | 07/05/2023 |
| Last Update Date | 08/10/2023 |
| Certification Date | 08/10/2023 |
| Medicare PECOS PAC ID | 8325409337 |
|---|---|
| Medicare Enrollment ID | O20230807001289 |
News Archive
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
Neuroscientists at The University of Texas Health Science Center at Houston have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.
New research from the University of Southampton could lead to enhanced MRI scans, producing brighter and more precise images, and potentially allowing the detection of cancerous cells before they cause health problems.
Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477230050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Emma Deem |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881299501 PECOS PAC ID: 5991168924 Enrollment ID: I20230824000291 |
News Archive
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
Neuroscientists at The University of Texas Health Science Center at Houston have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.
New research from the University of Southampton could lead to enhanced MRI scans, producing brighter and more precise images, and potentially allowing the detection of cancerous cells before they cause health problems.
Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.
› Verified 6 days ago
News Archive
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
Neuroscientists at The University of Texas Health Science Center at Houston have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.
New research from the University of Southampton could lead to enhanced MRI scans, producing brighter and more precise images, and potentially allowing the detection of cancerous cells before they cause health problems.
Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.
› Verified 6 days ago